Rubius Therapeutics Inc (NASDAQ:RUBY)
| 18.55 BATS BZX Real-Time Price As of 1:45pm ET |  -0.46 / -2.42%Today’s Change | 4.20 Today|||52-Week Range 38.71 | +144.40% Year-to-Date |
Latest RUBY News | Press Releases
No recent news for Rubius Therapeutics Inc.
Today’s Trading
| Previous close | 19.01 |
| Today’s open | 18.59 |
| Day’s range | 18.43 - 18.86 |
| Volume | 11,249 |
| Average volume (3 months) | 430,465 |
| Market cap | $1.7B |
Data as of 1:45pm ET, 09/28/2021
Growth & Valuation
| Earnings growth (last year) | -0.15% |
| Earnings growth (this year) | -3.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 10.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NGMNGM Biopharmaceutica... | -0.23 | -1.04% |
| ---- | ||
| MORMorphoSys AG | -0.15 | -1.21% |
| DRNADicerna Pharmaceutic... | -0.62 | -2.98% |
Data as of 1:56pm ET, 09/28/2021
Financials
| Next reporting date | November 17, 2021 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$167.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
